Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
BioPharmCatalyst and BYTE51 Partner to Enable Smarter Biotech Investing Insights
-
Altius Provides 2024 Year-End Project Generation Update
-
Changhong Spotlights AI Innovations at CES 2025, Asserting Global Leadership in Intelligent Technologies
-
Biocon Biologics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
BRImo Mobile Banking, a Worldwide Simplicity in Your Hand
-
Affinia Therapeutics Announces Development Candidate for BAG3 DCM and Completion of Pre-IND Meeting with the FDA
-
Genascence Announces Six-Month Results from Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
-
Net Asset Value(s)
-
Tata Elxsi delivers stable revenues in Q3 FY'25
-
Europe’s Oil and Gas Industry Turning to AI to Improve Operations Amid Energy Security Concerns
-
3 Critical Technology Trends Shaping 2025
-
Military Metals Selects SLR Consulting for Resource Estimation at Its Flagship Trojarová Antimony-Gold Property in Slovakia
-
Mason Resources Announces Fully Subscribed Private Placement Financing with Strong Insider Participation
-
How AI Can Help Dramatically Reduce Energy Demand and Emissions
-
EMX Provides Financial Update
-
Recognize Announces Majority Investment in Sprout
-
Constellation Brands Declares Quarterly Dividend
-
ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Novacium Partners with the French Army's Technical Section to Develop High-Capacity Silicon-Based Batteries
-
Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
GURU Organic Energy to Report Fourth Quarter and Fiscal Year 2024 Results
-
THE VISTRIA GROUP CLOSES ON $3 BILLION FOR FIFTH FLAGSHIP PRIVATE EQUITY FUND
-
Oxalis Solutions Awarded Coveted Seaport NxG Contract to Support U.S. Navy's Mission-Critical Needs
-
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
ReverseLogix CEO Gaurav Saran Named to the Top 50 Software CEOs of 2024 by The Software Report
-
Arcline Investment Management to Acquire Rotating Machinery Services, Inc.
-
Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors
-
Gibraltar to Present at CJS Securities 25th Annual "New Ideas for the New Year" Conference
-
Demesne Resources Ltd. Engages A-Z Mining Professionals to Write National Instrument 43-101 Technical Report for the IMA Mine Tungsten Property
-
Cristcot Announces Positive Phase 3 Results for Novel Hydrocortisone Acetate Suppository Administered with the Sephure® Suppository Applicator for the Treatment of Ulcerative Colitis of the Rectum
-
Redwire Camera Technology to Launch Onboard Firefly Aerospace Blue Ghost Lunar Lander’s First Robotic Moon Mission to Deliver NASA Science
-
MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR
-
Eos Energy Enterprises Announces Upcoming Investor Participation
-
Ribometrix Strengthens Leadership, Appoints William S. Marshall, Ph.D., as Chief Executive Officer and Katie Warner, Ph.D., as Chief Scientific Officer
-
PAN GLOBAL ADVANCES ESCACENA AND CÁRMENES PROJECTS IN SPAIN DURING SUCCESSFUL 2024 PROGRAM
-
Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025
-
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
-
Natural Grocers® Kicks Off Annual Resolution Reset Week, January 14-18, 2025
-
Alliance Witan PLC - Net Asset Value
-
Defense Metals Announces New Executive Appointments and Board Changes
-
Blackline Safety Announces Shipping of EXO 8 Area Monitor, New $1.6 Million Deal with Total Safety
-
Geologica Announces Antimony Exploration and Flow-Through Financing
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
MessageGears Predicts Key Consumer Enterprise Brand Trends for 2025
-
Peerbridge Health Unveils COR-INSIGHT Trial to Validate Revolutionary AI-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring
-
Happy Belly Closes 6th Consecutive Above-Market Non-Brokered Financing
-
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
-
PEPE Ascension Set to Go Live on Ethereum Layer 2 as New Meme Coin to Watch
-
PIZZA HUT® RELEASES SECOND ANNUAL PIZZA TRENDS REPORT UNVEILING AMERICA'S LOVE OF PIZZA AND 2025 INDUSTRY FORECASTING
-
BDR named 'Best in Consulting' and one of 'Washington's Top 100 Best Places to Work'
